# Catalio Capital Management's Biotech Investments: 40 Startups in Its Portfolio (2026) > The 40 Biotech startups Catalio Capital Management has backed, by stage: $5.5B raised between them. From the rounds we track; updated nightly. Source: https://millionrounds.com/portfolio-maps/catalio-capital-management-biotech-portfolio (Millionrounds; every figure on the page links to its filing or article) ## Stage not reported 16 - [Freenome](https://millionrounds.com/company/freenome) - [ArriVent](https://millionrounds.com/company/arrivent) - [COMPASS Pathways](https://millionrounds.com/company/compass-pathways) - [Affini-T Therapeutics](https://millionrounds.com/company/affini-t-therapeutics) - [AtaiBeckley](https://millionrounds.com/company/ataibeckley) - [Syndeio Biosciences](https://millionrounds.com/company/syndeio-biosciences) - [Protara Therapeutics](https://millionrounds.com/company/protara-therapeutics) - [Sherlock Biosciences](https://millionrounds.com/company/sherlock-biosciences) - [Fractyl Health](https://millionrounds.com/company/fractyl-health) - [Imbria Pharmaceuticals](https://millionrounds.com/company/imbria-pharmaceuticals) - [Ensoma](https://millionrounds.com/company/ensoma) - [Glympse Bio](https://millionrounds.com/company/glympse-bio) - [OSPRI](https://millionrounds.com/company/ospri) - [Xilis](https://millionrounds.com/company/xilis) - [Sunbird Bio](https://millionrounds.com/company/sunbird-bio) - [Neumora Therapeutics](https://millionrounds.com/company/neumora-therapeutics) ## Series C and later 9 - [AdvanCell](https://millionrounds.com/company/advancell) - [Recursion Pharmaceuticals](https://millionrounds.com/company/recursion-pharmaceuticals) - [*E* eGenesis](https://millionrounds.com/company/egenesis) - [Star Therapeutics](https://millionrounds.com/company/star-therapeutics) - [SetPoint Medical](https://millionrounds.com/company/setpoint-medical) - [Odyssey Therapeutics](https://millionrounds.com/company/odyssey-therapeutics) - [Aviceda Therapeutics](https://millionrounds.com/company/aviceda-therapeutics) - [Alentis Therapeutics](https://millionrounds.com/company/alentis-therapeutics) - [Orasis Pharmaceuticals](https://millionrounds.com/company/orasis-pharmaceuticals) ## Series B 8 - [Septerna](https://millionrounds.com/company/septerna) - [GlycoEra](https://millionrounds.com/company/glycoera) - [Lassen Therapeutics](https://millionrounds.com/company/lassen-therapeutics) - [*CT* Celsius Therapeutics](https://millionrounds.com/company/celsius-therapeutics) - [NextPoint Therapeutics](https://millionrounds.com/company/nextpoint-therapeutics) - [DNA Script](https://millionrounds.com/company/dna-script) - [Evvy](https://millionrounds.com/company/evvy) - [Spiral Therapeutics](https://millionrounds.com/company/spiral-therapeutics) ## Series A 7 - [Clasp Therapeutics](https://millionrounds.com/company/clasp-therapeutics) - [OnCusp Therapeutics](https://millionrounds.com/company/oncusp-therapeutics) - [Faze Medicines](https://millionrounds.com/company/faze-medicines) - [Pheast Therapeutics](https://millionrounds.com/company/pheast-therapeutics) - [Haystack Oncology](https://millionrounds.com/company/haystack-oncology) - [Volastra Therapeutics](https://millionrounds.com/company/volastra-therapeutics) - [Anagenex](https://millionrounds.com/company/anagenex) ## Segment by segment ### Stage not reported 16 startups · $1.9B raised - [**Freenome**](https://millionrounds.com/company/freenome) Freenome is a biotechnology company with a comprehensive multiomics platform for cancer detection using a routine blood draw. United States $553M - [**ArriVent**](https://millionrounds.com/company/arrivent) ArriVent develops pharmaceutical products to cure presently untreatable cancer. United States $325M - [**COMPASS Pathways**](https://millionrounds.com/company/compass-pathways) Compass Pathways is a mental health care company that focuses on developing therapies for treatment-resistant depression. United Kingdom $200M - [**Affini-T Therapeutics**](https://millionrounds.com/company/affini-t-therapeutics) Affini-T Therapeutics is a clinical-stage precision immunotherapy company based in Watertown, Massachusetts. United States $175M - [**AtaiBeckley**](https://millionrounds.com/company/ataibeckley) AtaiBeckley develops innovative mental health treatments that address significant unmet medical needs. Germany $150M - [**Syndeio Biosciences**](https://millionrounds.com/company/syndeio-biosciences) Syndeio Biosciences (from the Ancient Greek word "to connect") is a clinical-stage biotechnology company developing therapies to r United States $90M - [**Protara Therapeutics**](https://millionrounds.com/company/protara-therapeutics) Protara Therapeutics develops transformative therapies for people with cancer and rare diseases with limited treatment options. United States $75M - [**Sherlock Biosciences**](https://millionrounds.com/company/sherlock-biosciences) Sherlock Biosciences is an engineering biology company offering unparalleled breadth and versatility for diagnostic solutions. United States $66M ### Series C and later 9 startups · $2.4B raised - [**AdvanCell**](https://millionrounds.com/company/advancell) AdvanCell is radiopharmaceutical firm that has developed the Targeted Alpha Therapy platform technology, a cutting-edge cancer treatment. Australia $438M - [**Recursion Pharmaceuticals**](https://millionrounds.com/company/recursion-pharmaceuticals) Recursion Pharmaceuticals is a biotech company that develops a drug discovery platform and pipeline with machine learning. United States $339M - [*E* **eGenesis**](https://millionrounds.com/company/egenesis) United States $329M - [**Star Therapeutics**](https://millionrounds.com/company/star-therapeutics) Star Therapeutics is a clinical-stage biotechnology company based in South San Francisco, California, founded in 2018. United States $325M - [**SetPoint Medical**](https://millionrounds.com/company/setpoint-medical) SetPoint Medical is a commercial-stage medical technology company founded in 2007, focused on developing bioelectronic therapies f United States $256M - [**Odyssey Therapeutics**](https://millionrounds.com/company/odyssey-therapeutics) Odyssey Therapeutics creates precision immunomodulators and oncology medicines for patients with cancer and inflammatory diseases. United States $238M - [**Aviceda Therapeutics**](https://millionrounds.com/company/aviceda-therapeutics) Aviceda Therapeutics is a clinical-stage biotechnology company based in Cambridge, Massachusetts, founded in 2018. United States $208M - [**Alentis Therapeutics**](https://millionrounds.com/company/alentis-therapeutics) Alentis Therapeutics is a clinical-stage biotechnology company based in Basel, Switzerland. Switzerland $194M ### Series B 8 startups · $676M raised - [**Septerna**](https://millionrounds.com/company/septerna) Septerna is a biotech firm unlocking diverse drug discovery potential in G protein-coupled receptors across various diseases. United States $150M - [**GlycoEra**](https://millionrounds.com/company/glycoera) GlycoEra is a CustomGlycanengineering platform that unlocks the glycan-mediated biology to develop a pipeline of novel therapeutics. Switzerland $130M - [**Lassen Therapeutics**](https://millionrounds.com/company/lassen-therapeutics) Lassen Therapeutics is a clinical-stage biopharmaceutical company based in San Diego, California. United States $85M - [*CT* **Celsius Therapeutics**](https://millionrounds.com/company/celsius-therapeutics) Celsius Therapeutics is a biotechnology company that develops precision medicines for cancer and autoimmune disease patients. United States $83M - [**NextPoint Therapeutics**](https://millionrounds.com/company/nextpoint-therapeutics) NextPoint Therapeutics is a clinical-stage biotechnology company that develops therapeutics to treat cancer patients. United States $76M - [**DNA Script**](https://millionrounds.com/company/dna-script) DNA Script is a disruptive DNA synthesis company harnessing biology to accelerate breakthroughs in life science and human health. France $62M - [**Evvy**](https://millionrounds.com/company/evvy) Evvy is a women's health technology company based in New York, focused on addressing the gender health gap through precision medicine. United States $54M - [**Spiral Therapeutics**](https://millionrounds.com/company/spiral-therapeutics) Spiral Therapeutics is a clinical-stage pharmaceutical company delivering therapies for hearing loss. United States $36M ### Series A 7 startups · $523M raised - [**Clasp Therapeutics**](https://millionrounds.com/company/clasp-therapeutics) Clasp Therapeutics is a clinical-stage biotechnology company founded in 2020, focused on precision immuno-oncology. United States $150M - [**OnCusp Therapeutics**](https://millionrounds.com/company/oncusp-therapeutics) OnCusp Therapeutics, Inc. United States $100M - [**Faze Medicines**](https://millionrounds.com/company/faze-medicines) Faze Medicines was a biotechnology company based in Cambridge, Massachusetts, founded in 2020. United States $81M - [**Pheast Therapeutics**](https://millionrounds.com/company/pheast-therapeutics) Pheast Therapeutics is a clinical-stage immuno-oncology company based in Palo Alto, California, with operations in Redwood City. United States $76M - [**Haystack Oncology**](https://millionrounds.com/company/haystack-oncology) Haystack Oncology enables precision oncology to optimize treatment strategies. United States $56M - [**Volastra Therapeutics**](https://millionrounds.com/company/volastra-therapeutics) Volastra Therapeutics is a biotechnology company developing novel therapies for the treatment of metastatic cancers. United States $30M - [**Anagenex**](https://millionrounds.com/company/anagenex) Anagenex is a pre-clinical biotechnology company based in Lexington, Massachusetts, founded in 2019. United States $30M **How this map is made.** Every startup here works in Biotech and has raised money in a round we track that names Catalio Capital Management as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026. ## More portfolio maps [All portfolios](https://millionrounds.com/portfolio-maps) [Sector portfolio **Catalio Capital Management's AI portfolio** 10 startups · $1.9B](https://millionrounds.com/portfolio-maps/catalio-capital-management-ai-portfolio)[Portfolio map **Catalio Capital Management portfolio map** 70 startups · $11B](https://millionrounds.com/portfolio-maps/catalio-capital-management-portfolio-map)[Co-investors **Who invests with Catalio Capital Management** 55 co-investors](https://millionrounds.com/portfolio-maps/catalio-capital-management-co-investors)[Sector portfolio **Techstars' AI portfolio** 336 startups · $4.9B](https://millionrounds.com/portfolio-maps/techstars-ai-portfolio)[Sector portfolio **Alumni Ventures' AI portfolio** 302 startups · $36B](https://millionrounds.com/portfolio-maps/us-strategic-tech-fund-an-alumni-ventures-fund-ai-portfolio)[Sector portfolio **Andreessen Horowitz's AI portfolio** 259 startups · $426B](https://millionrounds.com/portfolio-maps/andreessen-horowitz-ai-portfolio) ## Raising from investors like Catalio Capital Management? Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports. [Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)